吲哚—脲基衍生物的设计、合成及α-葡萄糖苷酶抑制活性研究

Design, synthesis, and α-glucosidase inhibitory activity study of indole-urea derivatives

  • 摘要:
    目的  通过简单合成方法制备系列新型的非糖类结构α-葡萄糖苷酶抑制剂,并评价其抑制活性。
    方法  以2-甲基-1-氨基吲哚盐酸盐、异氰酸酯类为原料,一步法合成吲哚—脲基衍生物,采用酶活性实验进行α-葡萄糖苷酶抑制活性筛选,并对系列化合物进行构效关系分析。借助Discovery Studio软件和molinspiration网站预测化合物的药物代谢动力学特性和成药性。
    结果  简单、高效地合成了12个非糖结构的吲哚—脲基衍生物,同时α-葡萄糖苷酶抑制活性检测结果显示,化合物4f~4l的半数抑制浓度(IC50)远小于阳性对照阿卡波糖。对4f~4l的药物代谢动力学特性和成药性的预测结果表明,其符合Lipinski的成药性原则,且具有良好的吸收性。
    结论  吲哚—脲基衍生物有良好的α-葡萄糖苷酶抑制活性,符合成药特性,可作为先导化合物进行糖尿病药物的开发。

     

    Abstract:
    Objective  To design and synthesize novel non-sugar-based α-glucosidase inhibitors by a simple synthesis method and evaluate their inhibitory activity.
    Methods  Indole-urea derivatives were synthesized by a onestep method using 1-amino-2-methylindoline hydrochloride and isocyanates as raw materials, the inhibitory activity of α-glucosidase was screened by enzyme activity assays, and the structure-activity relationship of the series of compounds was analyzed. Additionally, the pharmacokinetic properties and drug-likeness of compounds were predicted with the help of Discovery Studio software and the molinspiration website.
    Results  In this study, 12 non-sugar-based indole-urea derivatives were synthesized simply and efficiently. Meanwhile, α -glucosidase inhibitory activity tests showed that the half-maximal inhibitory concentration (IC50) values of compounds 4f-4l were significantly lower than those of the positive control, acarbose. The pharmacokinetic properties and druglikeness prediction results of compounds 4f-4l indicated that they conform to Lipinski's rule of five and exhibit good oral absorbability.
    Conclusion  Indole-urea derivatives exhibit good α-glucosidase inhibitory activity, conform to drug-like properties, and can be used as lead compounds for the development of antidiabetic drugs.

     

/

返回文章
返回